Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1654 (1), 79-94
- https://doi.org/10.1016/j.bbcan.2003.09.002
Abstract
No abstract availableKeywords
This publication has 181 references indexed in Scilit:
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Angiopoietin 1 Promotes Tumor Angiogenesis and Tumor Vessel Plasticity of Human Cervical Cancer in MiceExperimental Cell Research, 2002
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- EXPRESSION OF THE VEGF-RECEPTOR Flt-1 IN BENIGN, PREMALIGNANT AND MALIGNANT PROSTATE TISSUESJournal of Urology, 2000
- Controlling the cellular brakesNature, 1999
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971